On 2017 Sep 22, Ryan Jajosky commented:

After asking the FDA for clarification, I was directed to the FDA's Blood Products Advisory Committee Transcript... which states the following "Babesia microti is among the most frequently transfusion transmitted infections reported to FDA, with associated fatalities, for which no donor testing is available."

https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM449523.pdf

The FDA has labelled the page number 9 (which corresponds to digital page number 11).

So, this statement may have been misinterpreted to mean that "Babesia is the most common transfusion transmitted infection in the United States".

On 2017 Sep 22, Ryan Jajosky commented:

After asking the FDA for clarification, I was directed to the FDA's Blood Products Advisory Committee Transcript... which states the following "Babesia microti is among the most frequently transfusion transmitted infections reported to FDA, with associated fatalities, for which no donor testing is available."

https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM449523.pdf

The FDA has labelled the page number 9 (which corresponds to digital page number 11).

So, this statement may have been misinterpreted to mean that "Babesia is the most common transfusion transmitted infection in the United States".